DBV Technologies appoints new members of scientific advisory board
This article was originally published in Clinica
Executive Summary
Epicutaneous diagnostics specialist DBV Technologies has appointed Gideon Lack and Philippe Eigenmann to its scientific advisory board. The new members, who are experts in paediatric food allergies, will help the company start its first US phase I trial in peanut allergy. Prof Lack is head of the children's allergy service at Guys' and St Thomas' NHS Foundation Trust, London, UK, and a professor of paediatric allergy at King's College, London, UK. Prof Eigenmann is an associate professor at the department of infants and adolescents at the H?pital Cantonal Universitaire de Genève, Switzerland.